An Antiviral Formulation with RNA Dependent RNA Polymerase and Viral DNA gyrase Suppressive Features for The Treatment of Coronaviral & adenoviral Infections
Description
An Antiviral Formulation Consisting of 3 protopanaxatriol-Class glucopyranoside Analouges, A Semi-Synthetic flavonol Glycoside Derivative and an Immuno-modulatory Ginsenoside RG3 Subvariant for The Treatment of Coronaviral & adenoviral Infections via Suppressing DNA Polymerase, RNA Dependent RNA Polymerase and Viral DNA gyrase and Modulating Anti-Inflammatory Cytokines Tnf-Alpha, IL-6, Nf-Kappa B and PGE2 to Suppress Potential Cytokine Storms simultaneously.
Inventors: ERDAL CAN ALKOCLAR & METEHAN YESIL
Resources
| Name |
Format |
Description |
Link |
|
11 |
|
https://download.data.public.lu/resources/an-antiviral-formulation-with-rna-dependent-rna-polymerase-and-viral-dna-gyrase-suppressive-features-for-the-treatment-of-coronaviral-adenoviral-infections/20200421-210349/15-antiviral-eng.docx |
|
10 |
|
https://download.data.public.lu/resources/an-antiviral-formulation-with-rna-dependent-rna-polymerase-and-viral-dna-gyrase-suppressive-features-for-the-treatment-of-coronaviral-adenoviral-infections/20200421-210349/7-viral-enfeksiyonlarin-tedavisine-yonelik-bir-kompozisyon-eng.doc |
|
11 |
|
https://download.data.public.lu/resources/an-antiviral-formulation-with-rna-dependent-rna-polymerase-and-viral-dna-gyrase-suppressive-features-for-the-treatment-of-coronaviral-adenoviral-infections/20200421-210349/2-viral.docx |
Tags
- sante
- antiviral
- health
- covid-19
- adenoviral